Nexgel (NXGLW) Operating Margin (2018 - 2025)
Nexgel (NXGLW) reported Operating Margin of 54.72% for Q4 2025, up 8238.0% on a YoY basis from 0.66% in Q4 2024, and up 321.45% quarter-over-quarter from 24.71% in Q3 2025.
Nexgel (NXGLW) Operating Margin (2018 - 2025) Analysis & Trends
Nexgel has reported Operating Margin for 8 years, with the latest figure at 54.72% in Q4 2025.
- For the quarter ending Q4 2025, Operating Margin rose 8238.0% year-over-year to 54.72%; the trailing twelve-month figure through Dec 2025 stood at 5.32% (up 3559.0% YoY), and the FY2025 full-year result was 5.32%, up 3558.0% from the prior year.
- Operating Margin for Q4 2025 stood at 54.72%, up from 24.71% in the prior quarter.
- The five-year high for Operating Margin was 54.72% in Q4 2025, with the low at 205.05% in Q1 2022.
- Historically, Operating Margin has averaged 96.36% across 5 years, with a median of 92.93% in 2024.
- Annual changes were most pronounced in 2021 — Operating Margin surged 50289 bps — and 2022, when it tumbled 1029 bps.
- Nexgel's Operating Margin stood at 166.42% in 2021, then gained by 10 bps to 149.05% in 2022, then grew by 24 bps to 112.66% in 2023, then jumped by 75 bps to 27.66% in 2024, then surged by 298 bps to 54.72% in 2025.
- The last three Operating Margin figures came in at 54.72% (Q4 2025), 24.71% (Q3 2025), and 22.05% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 30.87% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.97% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 5.74% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 34.92% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 20.96% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 4.04% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -2.87% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 13.65% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.44% |
| 10 | Nexgel | - | - | 819,000.00 | 54.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 54.72% |
| Sep 30, 2025 | -24.71% |
| Jun 30, 2025 | -22.05% |
| Mar 31, 2025 | -27.69% |
| Dec 31, 2024 | -27.66% |
| Sep 30, 2024 | -26.80% |
| Jun 30, 2024 | -73.19% |
| Mar 31, 2024 | -68.80% |
| Dec 31, 2023 | -112.66% |
| Sep 30, 2023 | -50.12% |
| Jun 30, 2023 | -65.30% |
| Mar 31, 2023 | -142.42% |
| Dec 31, 2022 | -149.05% |
| Sep 30, 2022 | -182.57% |
| Jun 30, 2022 | -127.99% |
| Mar 31, 2022 | -205.05% |
| Dec 31, 2021 | -166.42% |
| Sep 30, 2021 | -182.09% |
| Jun 30, 2021 | -132.61% |
| Mar 31, 2021 | -194.76% |